Board of Directors
-
BS, MBA
CEO, Movius
Previously MD at 247.AI and VP at Trimble Navigation
Worked across early to late stage start-ups and a Fortune 100 corporation
-
PhD, GradDipAppFin
CEO, Magic Pudding
Non-Executive Director, TechnologyOne
Member, Brisbane Angels
15 years experience in the biotech sector and 3 years of VC experience
-
AO, MBBS, MD, FRACP, FAA
Executive Director of the Victor Chang Cardiac Research Institute for 26 years
40 years of experience in clinical cardiovascular research
Co-Founder of Infensa Bioscience
-
BCom, MBA
Chair, George Clinical
Previously CEO of Chiltern International and VP of Global Operations at Charles River Labs
20 years of experience in the pharmaceutical services sector
-
Trustee of The Kinghorn Foundation
Director of Saluda Medical Inc
Has worked with several large not-for-profit medical research institutions
Has worked across early-stage med tech and biotechnology companies
-
BSc, PhD
CEO & MD, Alsonex
Previously CEO & MD of Pharmaxis (14 years) & Promics (now part of Teva)
More than 25 years of experience in the pharmaceutical sector
OUR TEAM
Chief Executive Officer
-
Business Founder of Infensa Bioscience
Previously Founder, CEO, CSO, VP of Protagonist Therapeutics
Total of 7 drug candidates in human clinical trials
30 years of experience in the biotech sector
Chief Scientific Officer
-
Co-Founder of Infensa Bioscience
Sole founder and inaugural CSO of Vestaron Corporation
Group Leader at the Institute for Molecular Bioscience, the University of Queensland
Inventor on 12 patents
Serves on SAB of three biotech companies
Chief Operating Officer
-
Previously COO and Company Secretary at Lowy Institute, Cancer Council and Prime Partners
Solicitor with experience across private, government and NFP sectors.
Young Australian Lawyer of the Year 2009.
CMC Director
-
Previously Head of Manufacturing Sciences and Technology at Lonza Biologics Guangzhou
3 years at CSL / CSL Behring
20 years of experience in biologics product development and manufacture
Head of Biology
-
Co-Founder of Infensa Bioscience
Group Leader, Institute for Molecular Bioscience at the University of Queensland
Lead Scientists
Head of Chemistry
-
PhD in Chemical Biology from the Max-Planck Institute for Molecular Physiology in Germany.
Worked as a peptide chemist in top research institutes in Germany, Switzerland and Australia, conducting academic and industry-funded research developing innovative chemistry for medicinal or biotechnological applications
15 years of experience in peptide and protein chemistry, including fine-tuning of cyclic peptide structure, synthesis of entire proteins and disulfide-rich toxins and improvement of drug-like properties of bioactive peptides
Head of Cell Biology
-
Master of Biotechnology from the University of Queensland
Research Assistant for Professor Melissa Little
Senior Research Assistant and Laboratory Manager for Associated Professor Nathan Palpant
Experienced in induced pluripotent stem cells, with a focus in cardiac and kidney differentiation
Contributor to high-impact publications such as Nature, Cell Stem Cell and Circulation
-
Medicinal Chemist with a PhD in Drug Design and Development from the University of Queensland
PhD focused on relaxin-3 ligand development to modulate food intake
Worked at Protagonist Therapeutics with a focus on peptide drug development
Driven to pursue novel therapeutics addressing unmet medical needs
-
BSc (Hons) in Biochemistry and PhD in Molecular Pharmacology from the University of Queensland
PhD focused on understanding the interaction between acid-sensing ion channel 1a and its modulator, PcTx1, for future therapeutic development
Worked in France on the R&D phase of the FP7 European Venomics project, producing venom-peptides for drug discovery screening
Over 10 years of experience in working with acid-sensing ion channels and their modulators
Skilled in producing and electrophysiologically characterising novel therapeutic candidates